Annals of Oncology · 2018 · 72 citations · 12 references
PharmacyPharmacokineticsPharmacologyCancer PharmacologyClinical PharmacologyHematologic OncologyDosing Of Immuno-oncology AgentsHematologic Malignancy PharmacotherapyHematologic Malignancy TherapyPharmacodynamics Of ImmunotherapiesPharmacokinetics Of Monoclonal AntibodiesToxicity ManagementChronic Lymphocytic Leukemia TherapyNon-hodgkin Lymphoma TherapyNon-hodgkin Lymphoma TreatmentRecommended Phase Ii DoseRefractory Chronic Lymphocytic LeukemiaRefractory Non-hodgkin LymphomaRelapsed Chronic Lymphocytic LeukemiaRelapsed Diffuse Large B-cell Lymphoma
12
Revised Response Criteria for Malignant Lymphoma
Bruce D. Cheson, Beate Pfistner, Malik E. Juweid et al. · Journal of Clinical Oncology · 2007 · 4.4K citations · Full text
Nathalie A. Johnson, Graham W. Slack, Kerry J. Savage et al. · Journal of Clinical Oncology · 2012 · 973 citations
Medicine, Cancer Biology, Oncology +13